TY - JOUR
T1 - Diminished chemokine and cytokine-induced adhesion of CD4+T cells to extracellular matrix ligands in patients with end-stage renal failure
AU - Zeltzer, E.
AU - Bernheim, J.
AU - Korzets, Z.
AU - Zeeli, D.
AU - Rathaus, M.
AU - Mekori, Y. A.
AU - Hershkoviz, R.
PY - 2000
Y1 - 2000
N2 - Background: Cell-mediated immunity is impaired in uremia. Cell-matrix interactions of immune cells such as CD4+T lymphocytes with extracellular matrix are an important requirement for an intact immune response. The adherence of CD4+T cells of healthy subjects (normal T cells) to ECM components is inhibited in the prescence of uremic serum. Such decreased adhesive capacity is also found in T cells of dialysis patients. Various chemokines and cytokines affect the attachment of CD4+T cells to ECM. Objective: To evaluate chemokine (MIP-1β and RANTES) and tumor necrosis factor-α-induced adhesion of CD4+T cells to ECM in a uremic milieu. Methods: We examined adhesion of normal CD4+T cells (resting and activated) to intact ECM in response to soluble or bound chemokines (MIP-1β and RANTES) and to TNF-α following incubation in uremic versus normal serum. Thereafter, we evaluated the adhesion of resting CD4+T cells from dialysis patients in a similar fashion and compared it to that obtained from a healthy control group. Results: Addition of uremic serum diminished soluble and anchored chemokine-induced attachment of normal resting and activated CD4+T cells to ECM compared to a normal milieu (a peak response of 10-11% vs. 24-29% for soluble chemokines, P<0.001; 12-13% vs. 37-39% for bound chemokines on resting cells, P<0.01; and 18-20% vs. 45-47% for bound chemokines on activated cells, P<0.02). The same pattern of response was noted following stimulation with immobilized TNF-α (7 vs. 12% for resting cells, P<0.05; 17 vs. 51% for activated cells, P<0.01). Adherence of dialysis patients' cells to ECM following stimulation with both bound chemokines was reduced compared to control T cells (15-17% vs. 25-32%, P<0.0000). In contrast, adherence following stimulation by TNF-α was of equal magnitude. Conclusions: Abnormal adhesive capacity of T lymphocytes to ECM in uremia may, in part, be related to a diminished response to MIP-1β, RANTES and TNF-α. However, whereas reduced adhesion to chemokines was present in both normal CD4+T cells in a uremic environment and in dialysis patients' T cells, TNF-α-induced adhesion was found to be inhibited only in normal cells in a uremic milieu.
AB - Background: Cell-mediated immunity is impaired in uremia. Cell-matrix interactions of immune cells such as CD4+T lymphocytes with extracellular matrix are an important requirement for an intact immune response. The adherence of CD4+T cells of healthy subjects (normal T cells) to ECM components is inhibited in the prescence of uremic serum. Such decreased adhesive capacity is also found in T cells of dialysis patients. Various chemokines and cytokines affect the attachment of CD4+T cells to ECM. Objective: To evaluate chemokine (MIP-1β and RANTES) and tumor necrosis factor-α-induced adhesion of CD4+T cells to ECM in a uremic milieu. Methods: We examined adhesion of normal CD4+T cells (resting and activated) to intact ECM in response to soluble or bound chemokines (MIP-1β and RANTES) and to TNF-α following incubation in uremic versus normal serum. Thereafter, we evaluated the adhesion of resting CD4+T cells from dialysis patients in a similar fashion and compared it to that obtained from a healthy control group. Results: Addition of uremic serum diminished soluble and anchored chemokine-induced attachment of normal resting and activated CD4+T cells to ECM compared to a normal milieu (a peak response of 10-11% vs. 24-29% for soluble chemokines, P<0.001; 12-13% vs. 37-39% for bound chemokines on resting cells, P<0.01; and 18-20% vs. 45-47% for bound chemokines on activated cells, P<0.02). The same pattern of response was noted following stimulation with immobilized TNF-α (7 vs. 12% for resting cells, P<0.05; 17 vs. 51% for activated cells, P<0.01). Adherence of dialysis patients' cells to ECM following stimulation with both bound chemokines was reduced compared to control T cells (15-17% vs. 25-32%, P<0.0000). In contrast, adherence following stimulation by TNF-α was of equal magnitude. Conclusions: Abnormal adhesive capacity of T lymphocytes to ECM in uremia may, in part, be related to a diminished response to MIP-1β, RANTES and TNF-α. However, whereas reduced adhesion to chemokines was present in both normal CD4+T cells in a uremic environment and in dialysis patients' T cells, TNF-α-induced adhesion was found to be inhibited only in normal cells in a uremic milieu.
KW - CD4+T cell
KW - Cell adhesion molecules
KW - Chemokines
KW - Cytokines
KW - Dialysis
KW - Extracellular matrix
KW - Integrins
KW - Tumor necrosis factor-α
KW - Uremia
UR - http://www.scopus.com/inward/record.url?scp=0033843154&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0033843154
SN - 1565-1088
VL - 2
SP - 282
EP - 286
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 4
ER -